NDC Package 70720-101-02 Varubi

Rolapitant Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70720-101-02
Package Description:
2 TABLET in 1 BLISTER PACK
Product Code:
Proprietary Name:
Varubi
Non-Proprietary Name:
Rolapitant
Substance Name:
Rolapitant Hydrochloride
Usage Information:
Rolapitant is used with other medications to help prevent delayed nausea and vomiting caused by cancer drug treatment (chemotherapy). It works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This drug is not recommended for use in children younger than 2 years due to risk of serious side effects.
11-Digit NDC Billing Format:
70720010102
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
2 EA
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Tersera Therapeutics Llc
Dosage Form:
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Sample Package:
No
FDA Application Number:
NDA206500
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
10-07-2015
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

NDC HCPCS Crosswalk

This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

NDC 70720-101-02 HCPCS crosswalk information with package details and bill units information.

NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
70720010102J8670Rolapitant, oral, 1mg1 MG21180180

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70720-101-02?

The NDC Packaged Code 70720-101-02 is assigned to a package of 2 tablet in 1 blister pack of Varubi, a human prescription drug labeled by Tersera Therapeutics Llc. The product's dosage form is tablet and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package.

Is NDC 70720-101 included in the NDC Directory?

Yes, Varubi with product code 70720-101 is active and included in the NDC Directory. The product was first marketed by Tersera Therapeutics Llc on October 07, 2015 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 70720-101-02?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 2.

What is the 11-digit format for NDC 70720-101-02?

The 11-digit format is 70720010102. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-270720-101-025-4-270720-0101-02